Legislative Proposal, Bill or Resolution

• The upcoming Food and Drugs Act Modernization legislative proposal (Act and Regulations) as it relates to improving the efficiency of the drug review and approval process.

Legislative Proposal, Bill or Resolution, Regulation

• Food and Drugs Act & Regulations with respect to Drug Export Restrictions and international trade.
• The Food and Drugs Act and Regulations with respect to their impact on addiction treatments.

Policies or Program

• A national pharmacare strategy with respect to the need for full coverage/reimbursement of opioid dependence treatments and addiction treatments.
• Common Drug Review with respect to reimbursement decisions and the approval process.
• Coverage of opioid dependence treatments and addiction treatments with respect to Canadian Forces returning to Canada from active duty overseas.
• Government of Canada Drug Plans, with respect to the reimbursement of therapeutic products relevant beneficiaries.
• Non-Insured Health Benefits under Health Canada with regards to reimbursement criteria of opioid dependence & addiction treatments for First Nations, Inuit and Metis in Canada.
• The National Anti-Drug Strategy with respect to public relations and awareness programs relating to addiction and opioid dependence.
• The federal Science & Technology Strategy and/or any federal Government policy or program initiatives to support Research and Development in Canada, and advocate for the development of a pharmaceutical sectoral strategy in support of more research & development in Canada
• The national prescription drug abuse strategy, "First Do No Harm: Responding to Canada's Prescription Drug Crisis" with respect to risk mitigation strategies for the pharmaceutical industry to ensure high quality patient care, reform of the drug approval process in Canada and the launch of a national prescription drug monitoring and surveillance system.

Regulation

• Patented Medicine Prices Review Board (PMPRB) Regulations as it relates to reporting requirements and pricing guidelines.
• Patented Medicines Regulations (Notice of Compliance) with respect to regulating intellectual property for therapeutic products